Document is current
Any future updates will be listed below
-
Authors
Molla, Eshetu
Fekadu, Eyob
Biyazen, Zemed
Kassa, Fikregabrail Aberra
Teklewold, Melat Gebremedhin
Nigussie, Tedros
Ebabu, Mihret
Mande, Mequanint
Shimeles, Muluye
Achalu, Daniel Legese
Feleke, Solomon
Umer, Mamud
Daba, Derese Bekele
Fantahun, Anneleye
Mesfin, Miraf
Bayissa, Adamu
Pal, Sampa
Yemane, Dagmawi Hailu
Gerth-Guyette, Emily
Duparc, Stephan
Domingo, Gonzalo J.
Gadisa, Endalamaw
-
Funding
Funding for this research was provided by:
Unitaid
- License Information
-
More Information
Article History
Received: 25 December 2025
Accepted: 6 June 2026
First Online: 17 June 2026
Declarations
Ethics approval and consent to participate: The main study protocol, as well as the protocol for this ancillary study, was reviewed and approved by the Armauer Hansen Research Institute and All Africa Leprosy Rehabilitation and Training Center Ethics Review Committee (Protocol number: PO-59–22), the National Research Ethics Review Committee (NRERC, Reference number: 17/256/695/23), the Ethiopian Food and Drug Authority (EFDA, Unique ID number: ET-CT-0038), and the WHO Ethics Review Committee (Protocol ID: ERC.0003842). Before sample collection, informed written consent and/or assent were obtained from all participants and/or the parents/guardians of the children.
Consent for publication: Not applicable.
Competing interests: The authors declare no competing interests.
